AD5-NCOV

Approval Year

Substance Class	Structurally Diverse Created by `admin` on `Wed Apr 02 12:49:27 GMT 2025` Edited by `admin` on `Wed Apr 02 12:49:27 GMT 2025`
Source Materials Class	ORGANISM
Source Materials Type	VIRUS
Source Materials State	LIVE NON-REPLICATING GENETICALLY MODIFIED
Organism Family	Adenoviridae
Organism Genus	Mastadenovirus
Organism Species	human mastadenovirus d
Author	NONE
Infraspecific Type	RECOMBINANT VECTOR
Infraspecific Name	TYPE 5 Ad5-nCoV
Part	whole
Record UNII	5AHC3V2UQS
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AD5-NCOV

Common Name

English

CONVIDICEA

Preferred Name

English

RECOMBINANT ADENOVIRUS TYPE 5 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN (CANSINO BIOLOGICS)

Common Name

English

AD5-NCOV (RECOMBINANT ADENOVIRUS TYPE 5 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN)

Common Name

English

Code System Code Type Description

FDA UNII

5AHC3V2UQS

Created by admin on Wed Apr 02 12:49:27 GMT 2025 , Edited by admin on Wed Apr 02 12:49:27 GMT 2025

PRIMARY

FDA UNII

5AHC3V2UQS

Created by admin on Wed Apr 02 12:49:27 GMT 2025 , Edited by admin on Wed Apr 02 12:49:27 GMT 2025

PRIMARY

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->VACCINE ANTIGEN

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
TRANSGENE					SARS-COV-2/HUMAN/USA/WA-CDC-WA1/2020 S GENE	2P8AY5G2GA